BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Podcasts

  The Weekly

  Join BioSpace’s editorial team as they discuss the biggest stories in biopharma. New episodes out every Wednesday.

  September 5, 2024
• Podcasts

  Denatured

  Join BioSpace Insights and guests as we dive into the biggest challenges facing biopharma, whether it’s diversity in clinical trials, artificial intelligence or navigating evolving regulatory frameworks in drug development.

  September 5, 2024
• 

  Business

  BioMarin Rolls Out $4B Revenue Expectations, as Analysts Wonder About Pipeline

  BioMarin executives sought to calm an anxious investor base Wednesday with a public address and pledge to achieve a nearly 50% bump in annual revenue by 2027. But analysts were left wanting.

  September 5, 2024

   · 

  7 min read

   · 

  Annalee Armstrong
• 

  GLP-1

  UK’s MHRA Finds No Risk of Suicidal Ideation, Self-Harm With GLP-1 Drugs

  Like its U.S. and European counterparts, Britain’s Medicines and Healthcare Products Regulatory Agency found no conclusive link between the use of GLP-1s and a heightened risk of suicidal and self-injury thoughts.

  September 5, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Obesity

  Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases

  A broad indication for MariTide could help Amgen secure Medicare coverage for the treatment following FDA approval, CEO Robert Bradway said at Wednesday’s Morgan Stanley Global Healthcare Conference.

  September 5, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Manufacturing

  Novartis Starts Construction on Two US Sites to Bolster Radioligand Therapy Manufacturing

  The company is building a new facility in California, its third U.S.-based radioligand therapy production site, and expanding an Indianapolis site for producing isotopes for cancer treatment.

  September 5, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Layoffs

  IN8bio to Lay Off About 49% of Employees

  Facing financial challenges, IN8bio is looking to preserve cash resources through a pipeline prioritization and layoffs at its New York City and Birmingham, Alabama, sites.

  September 5, 2024

   · 

  1 min read

   · 

  Angela Gabriel
• 

  Diabetes

  Lilly Gains Ground on Novo With Positive Phase III Readouts for Weekly Insulin

  Eli Lilly’s weekly insulin injection efsitora alfa secured two late-stage victories on Thursday in a potential blow to rival Novo Nordisk, which in July failed to secure the FDA’s approval for its basal insulin icodec.

  September 5, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Business

  Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

  September 5, 2024

   · 

  2 min read
• Press Releases

  Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September 2024

  September 5, 2024

   · 

  1 min read